
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 16.05.2026
Psychemedics Corporation Langfristiger Schuldenstrom 2011-2026 | PMD
Langfristiger Schuldenstrom Jährlich Psychemedics Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 452 K | 1.05 M | 1.04 M | 984 K | 875 K | 963 K | 416 K | 957 K | 1.14 M | 1.62 M | 1.4 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.62 M | 416 K | 991 K |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Castle Biosciences
CSTL
|
1.32 M | $ 20.03 | 4.32 % | $ 581 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.41 | 2.88 % | $ 496 M | ||
|
Guardant Health
GH
|
27.7 M | $ 114.97 | 17.09 % | $ 14.4 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 115.09 | 1.36 % | $ 9.49 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.8 | - | $ 7.96 M | ||
|
Illumina
ILMN
|
79 M | $ 141.92 | 0.17 % | $ 22.6 B | ||
|
Celcuity
CELC
|
54 K | $ 140.34 | 7.16 % | $ 6.56 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 2.39 | 21.32 % | $ 3.18 M | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 21.15 | 3.02 % | $ 1.13 B | ||
|
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 96.09 | 3.44 % | $ 6.49 B | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 421.87 | 0.47 % | $ 12.2 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 082.67 | 3.04 % | $ 22.3 B | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
National Research Corporation
NRC
|
451 K | $ 19.26 | 2.72 % | $ 431 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Natera
NTRA
|
7.64 M | $ 204.92 | 4.53 % | $ 20.2 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Personalis
PSNL
|
6.89 M | $ 7.95 | 12.93 % | $ 709 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 156.03 | 2.36 % | $ 7.73 B | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.9 | 6.08 % | $ 1.14 B | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 3.81 | 7.32 % | $ 353 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.74 | 2.65 % | $ 25.4 B | ||
|
Thermo Fisher Scientific
TMO
|
275 M | $ 451.79 | 0.89 % | $ 170 B | ||
|
Senseonics Holdings
SENS
|
496 K | $ 5.71 | 3.07 % | $ 238 M | ||
|
Twist Bioscience Corporation
TWST
|
13.8 M | $ 53.66 | 8.4 % | $ 3.21 B | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
726 K | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.35 | -1.26 % | $ 5.4 M | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 257.42 | 1.47 % | $ 21.4 B | ||
|
Waters Corporation
WAT
|
31.1 M | $ 341.32 | 2.42 % | $ 20.3 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 8.83 | 5.75 % | $ 1.92 B | ||
|
Quest Diagnostics Incorporated
DGX
|
174 M | $ 193.75 | 1.92 % | $ 21.5 B |